E-LIB Suche - Ergebnisse für: Tsai, Donald E

1

Fixed-Duration Pirtobrutinib plus Venetoclax with or withou..:

Roeker, Lindsey Elizabeth ; Woyach, Jennifer A. ; Cheah, Chan Yoon Y...
Blood Journal. , 2024

Link: https://doi.org/10.1182/..

2

Safety of extended pirtobrutinib exposure in relapsed and/o..:

Roeker, Lindsey E. ; Coombs, Catherine C. ; Shah, Nirav N....
Acta Haematologica. , 2024

Link: https://doi.org/10.1159/..

3

Tabelecleucel for EBV+ PTLD after allogeneic HCT or SOT in ..:

Nikiforow, Sarah ; Whangbo, Jennifer S. ; Reshef, Ran...
Blood Advances. 8 (2024) 12 - p. 3001-3012 , 2024

Link: https://doi.org/10.1182/..

4

CT-166 Long-Term Safety With ≥12 Months of Pirtobrutinib in..:

Muehlenbein, Catherine E. ; Coombs, Catherine C. ; Shah, Nirav N....
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S520 , 2023

Link: https://doi.org/10.1016/..

5

POSTER: CT-166 Long-Term Safety With ≥12 Months of Pirtobru..:

Muehlenbein, Catherine E. ; Coombs, Catherine C. ; Shah, Nirav N....
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S229 , 2023

Link: https://doi.org/10.1016/..

6

POSTER: CT-168 Comparison of Bleeding-Related Events in Pat..:

Konig, Heiko ; Tam, Constantine S. ; Lamanna, Nicole...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S229 , 2023

Link: https://doi.org/10.1016/..

7

P1087: PIRTOBRUTINIB IN COVALENT BTK-INHIBITOR PRE-TREATED ..:

Jurczak, Wojciech ; Luigi Zinzani, Pier ; Eyre, Toby A....
HemaSphere. 7 (2023) S3 - p. e45636b5 , 2023

Link: https://doi.org/10.1097/..

8

P618: LONG-TERM SAFETY WITH ≥12 MONTHS OF PIRTOBRUTINIB IN ..:

Jurczak, Wojciech ; Coombs, Catherine C. ; Shah, Nirav N....
HemaSphere. 7 (2023) S3 - p. e6206253 , 2023

Link: https://doi.org/10.1097/..

9

POSTER: MCL-155 Pirtobrutinib in Covalent BTK Inhibitor Pre..:

Wang, Michael L. ; Shah, Nirav N. ; Jurczak, Wojciech...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S213 , 2023

Link: https://doi.org/10.1016/..

10

MCL-155 Pirtobrutinib in Covalent BTK Inhibitor Pre-Treated..:

Wang, Michael L. ; Shah, Nirav N. ; Jurczak, Wojciech...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S459 , 2023

Link: https://doi.org/10.1016/..

11

CT-168 Comparison of Bleeding-Related Events in Patients Wh..:

Konig, Heiko ; Tam, Constantine S. ; Lamanna, Nicole...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S520-S521 , 2023

Link: https://doi.org/10.1016/..

12

P1088: COMPARISON OF BLEEDING-RELATED EVENTS IN PATIENTS WH..:

Lamanna, Nicole ; Tam, Constantine ; Jurczak, Wojciech...
HemaSphere. 7 (2023) S3 - p. e724362f , 2023

Link: https://doi.org/10.1097/..

13

ABCL-040: Pirtobrutinib (LOXO-305), a Next-Generation, High..:

Cohen, Jonathon B. ; Shah, Nirav N. ; Alencar, Alvaro J....
Clinical Lymphoma Myeloma and Leukemia. 21 (2021) - p. S378-S379 , 2021

Link: https://doi.org/10.1016/..

14

Oral Abstract: CLL-039: Pirtobrutinib (LOXO-305), a Next-Ge..:

Coombs, Catherine C. ; Pagel, John M. ; Shah, Nirav N....
Clinical Lymphoma Myeloma and Leukemia. 21 (2021) - p. S202 , 2021

Link: https://doi.org/10.1016/..

15

CLL-039: Pirtobrutinib (LOXO-305), a Next-Generation, Highl..:

Coombs, Catherine C. ; Pagel, John M. ; Shah, Nirav N....
Clinical Lymphoma Myeloma and Leukemia. 21 (2021) - p. S315-S316 , 2021

Link: https://doi.org/10.1016/..